Nextvein LLC

Nextvein LLC specializes in transportable, non-powered medical equipment stands. These stands are designed to support and stabilize portable devices like infusion pumps or monitoring systems during patient care, ensuring secure positioning and mobility in clinical environments. The company’s focus is on Class I devices, which are generally considered low-risk and do not require pre-market approval but must still comply with regulatory standards.

Nextvein LLC is based in the United States, where it operates under FDA regulations. Since its devices fall under Class I classification, they are subject to general controls (e.g., labeling, manufacturing practices) rather than pre-market approval. The U.S. location means its products must meet FDA requirements, including listing in the FDA’s Unique Device Identifier (UDI) database, which ensures traceability and compliance tracking.

Yes, Nextvein’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is critical because it provides a standardized way to identify medical devices throughout their lifecycle—from manufacturing to patient use. For healthcare providers and regulators, UDI listings ensure accurate tracking, reduce errors in device selection, and support compliance with reporting requirements. Since Nextvein’s products are Class I, UDI listing helps maintain transparency without requiring additional pre-market scrutiny.

Nextvein’s devices are classified as Class I medical devices by the FDA. This classification applies to products deemed to pose minimal risk to patients and users, such as non-powered stands for supporting portable equipment. Class I devices typically require general controls (e.g., proper labeling, manufacturing quality systems) but do not undergo pre-market approval. The classification reflects that these stands are intended for straightforward, low-risk applications—like stabilizing infusion pumps—where safety risks are mitigated by design and basic regulatory oversight.